🚨 New from our lab! Huge congrats to my amazing colleague and friend Vindhya Vijay —so proud of this work! A powerful resource for the cholangio field combining multi-omics and CRISPR screens across 63 biliary tract cancer (BTC) cell lines. Check it out! TargetCancer Fdn Cholangiocarcinoma Foundation

Biliary tract cancers are aggressive and understudied. This landmark study,led by my brilliant colleague and friend Vindhya Vijay, profiles 63 BTC cell lines with multi-omics and CRISPR screens, revealing subtypes and vulnerabilities. Honored to contribute! Cholangiocarcinoma Foundation TargetCancer Fdn

massgeneralbrigham.org/en/about/newsr… Mass General Brigham Research Gad Getz Laboratory Francisca Vazquez TargetCancer Fdn Cholangiocarcinoma Foundation

Nabeel Mass General Cancer Center was not ready to accept that “Lack of model systems would prevent the community to study this cancer”. I feel lucky to see it closely and play a small part in the early development. Very inspiring.TargetCancer Fdn

Excited to share our comprehensive cell line atlas for biliary tract cancer (BTC) in collab with Dr. Nabeel Bardeesy Mass General Cancer Center & Francisca Vazquez, and led by Vindhya Vijay & Negin Karisani! doi.org/10.1158/2159-8… The Cancer Dependency Map Cancer Discovery Also see: massgeneralbrigham.org/en/about/newsr…

A new cell line atlas of biliary tract cancers uncovers new subtypes and potential drug targets for better treatment of these deadly diseases. Learn more: broad.io/DepMap-BTCs Mass General Brigham Research TargetCancer Fdn